跳至主要内容
临床试验/IRCT20190121042447N1
IRCT20190121042447N1招募中3 期

Evaluating the efficacy of Erythropoietin and Intravenous Iron on transfusion requirements in patients undergoing cardiac surgery

Tehran University of Medical Sciences0 个研究点目标入组 154 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
154

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • patient over 18 years old CABG candidate if hemoglobin concentration less than 12 g/dl in women and less than 13 g/dl in men 1-ferritin < 30 mcg/l 2-ferritin 30-100 mcg /l or TSAT<20% OR CRP>5 mg/l

排除标准

  • Patients with uncontrolled hypertension (BP>180/110) -platelet count more than 450,000/mm3 history of thromboembolism, history of seizure, history of malignant disease liver dysfunction(transaminase>3ULN), confirmed renal impairment (serum creatinine[Cr]2 mg/dl), aplastic anemia hypersensitivity to iron history of erythropoeitin use

研究者

相似试验

Evaluating the efficacy of Erythropoietin and... | 临床试验